STING1 and prostate cancer: Nevertheless, in a prostate cancer model, EZH2 inhibition in tumor organoids was able to induce stimulator of interferon genes (STING)-dependent activation of genes involved in antigen presentation, Th1 chemokine signaling and interferon response, including PD-L1 gene expression [129].